Allergy News and Research RSS Feed - Allergy News and Research

The term allergy encompasses a wide range of conditions; it is not a disease in itself. In 1906 Clemens von Pirquet was the first to describe allergies as a changed or altered reaction of the immune system in response to exposure to foreign proteins. These days the term allergy – medically termed hypersensitivity, signifies an exaggerated reaction to foreign substances.
Allakos secures additional $10M investment to expand its development portfolio

Allakos secures additional $10M investment to expand its development portfolio

Allakos Inc. announced today that it has secured an additional $10 million investment from current investors to fund development of an additional therapeutic antibody. [More]
Anaphylaxis Campaign to hold special event to help prevent food business errors

Anaphylaxis Campaign to hold special event to help prevent food business errors

The Anaphylaxis Campaign is set to hold a special event for the food industry on Tuesday 7th October 2014 to help prevent food business errors reaching crisis point. [More]
Individuals can improve asthma symptoms by avoiding air pollution

Individuals can improve asthma symptoms by avoiding air pollution

People who suffer from asthma may think there's not a lot they can do to control their asthma besides properly taking medications and avoiding allergic triggers. [More]
Seven NIH research contracts awarded to identify novel adjuvant candidates

Seven NIH research contracts awarded to identify novel adjuvant candidates

The National Institute of Allergy and Infectious Diseases, part of the National Institutes of Health, has awarded seven research contracts to discover and characterize new adjuvants, or substances formulated as part of vaccines to enhance their protective ability. [More]
Mild autumn could bring more misery for hayfever sufferers

Mild autumn could bring more misery for hayfever sufferers

Researchers at the University of Leicester have recorded a rare type of pollen that is a potent trigger of hayfever and asthma symptoms at record levels for the first time in four decades. [More]
New comic book explains to children about Primary Immunodeficiency

New comic book explains to children about Primary Immunodeficiency

Primary Immunodeficiency (PID) refers to a group of disorders characterised by limited or absent function of the immune system. The majority of PIDs are inherited defects meaning that a component is either missing or does not function normally, resulting in increased susceptibility to infection. About 1 in 500 people are born with PID and doctors’ estimate that approximately 5,000 people may be affected by PID in the UK. [More]
Australian researchers use hookworms to reduce symptoms of celiac disease

Australian researchers use hookworms to reduce symptoms of celiac disease

Australian researchers have achieved groundbreaking results in a clinical trial using hookworms to reduce the symptoms of celiac disease. [More]
Triple-punch of antibodies prevents, wipes out hepatitis C infection in laboratory mice

Triple-punch of antibodies prevents, wipes out hepatitis C infection in laboratory mice

A triple-punch of antibodies both prevented hepatitis C infection and wiped out the disease after it had established itself in laboratory mice, according to a study led by Princeton University researchers. [More]

Study: Healthcare.gov costs top $2B

The finding by a Bloomberg Government analysis exceeds the cost estimates provided by the Obama administration. Meanwhile, an administration official says efforts are "continuing, step by step" to improve the health insurance website, but also steers clear of specific pledges. [More]
NIH awards grants to 11 research groups to establish AMP RA/Lupus Network

NIH awards grants to 11 research groups to establish AMP RA/Lupus Network

The National Institutes of Health has awarded grants to 11 research groups across the United States to establish the Accelerating Medicines Partnership in Rheumatoid Arthritis and Lupus (AMP RA/Lupus) Network. [More]
NIH, CSU scientists provide evidence that supports camels as primary carrier of MERS-CoV

NIH, CSU scientists provide evidence that supports camels as primary carrier of MERS-CoV

National Institutes of Health and Colorado State University scientists have provided experimental evidence supporting dromedary camels as the primary reservoir, or carrier, of Middle East respiratory syndrome coronavirus (MERS-CoV). [More]
Understanding ways to treat, cure eosinophilic gastritis

Understanding ways to treat, cure eosinophilic gastritis

Investigators at Cincinnati Children's Hospital Medical Center have published the first study to extensively characterize eosinophilic gastritis (EG). [More]
Researchers say that environment plays much stronger role than genetics in eosinophilic esophagitis

Researchers say that environment plays much stronger role than genetics in eosinophilic esophagitis

Researchers have found that environment has a much stronger role than genetics in eosinophilic esophagitis (EoE), a severe, often painful food allergy that renders children unable to eat a wide variety of foods. [More]
ACP and 20 other groups applaud Senate bill that ensures primary care access for women, children

ACP and 20 other groups applaud Senate bill that ensures primary care access for women, children

The efforts and leadership of Senators Sherrod Brown (D-Ohio) and Patty Murray (D-Wash.) to ensure access to vital primary care services were lauded yesterday by the American College of Physicians and 20 other organizations, representing internal medicine and related subspecialties. [More]
Food allergies in inner-city children: an interview with Dr. Robert Wood

Food allergies in inner-city children: an interview with Dr. Robert Wood

The general interest is in trying to better define the true prevalence of food allergy; not just how common it is, but whether it's becoming more common over time. [More]
Dry roasted peanuts more likely to trigger allergy risk

Dry roasted peanuts more likely to trigger allergy risk

Dry roasted peanuts are more likely to trigger an allergy to peanuts than raw peanuts, suggests an Oxford University study involving mice. [More]
Soligenix awarded $24.7 million contract to advance development of Rivax vaccine

Soligenix awarded $24.7 million contract to advance development of Rivax vaccine

Soligenix, Inc., a late-stage biopharmaceutical company developing products that address unmet medical needs in the areas of inflammation, oncology and biodefense, announced today that it has been awarded a contract valued at up to $24.7 million inclusive of options by the US Department of Health and Human Service's National Institutes of Health (specifically funded by the National Institute of Allergy and Infectious Diseases or NIAID). [More]
Researchers show link between childhood asthma and prenatal exposure to phthalates

Researchers show link between childhood asthma and prenatal exposure to phthalates

Researchers at the Columbia Center for Children's Environmental Health at the Mailman School of Public Health are the first to demonstrate an association between childhood asthma and prenatal exposure to two phthalates used in a diverse array of household products. Results appear online in the journal Environmental Health Perspectives. [More]
WellStar establishes new health park in East Cobb

WellStar establishes new health park in East Cobb

WellStar East Cobb Health Park opened its doors September 15, serving as a comprehensive, one-stop shop for outpatient medical needs. [More]
FDA approves Contrave extended-release tablets for chronic weight management

FDA approves Contrave extended-release tablets for chronic weight management

Takeda Pharmaceuticals U.S.A., Inc. and Orexigen® Therapeutics, Inc. jointly announced today that the U.S. Food and Drug Administration has approved Contrave® extended-release tablets as an adjunct to a reduced-calorie diet and increased physical activity for chronic weight management in adults with an initial body mass index of 30 kg/m2 or greater (obese), or 27 kg/m2 or greater (overweight) in the presence of at least one weight-related comorbid condition. [More]